Botulinum toxin therapy of cervical dystonia: duration of therapeutic effects

Journal of Neural Transmission

Volumn 122, Issue 2, 2015, Pages 297-300

  Dressler, Dirk ^a   Tacik, Pawel ^a   Adib Saberi, Fereshte ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Botulinum toxin; Cervical dystonia; Duration; Inter injection intervals; Therapeutic use; Treatment effect

Indexed keywords

BOTULINUM TOXIN; NEUROTOXIN;

ADULT; FEMALE; FOLLOW UP; HUMAN; IATROGENIC DISEASE; MALE; MIDDLE AGED; TIME; TORTICOLLIS;

ADULT; BOTULINUM TOXINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; NEUROTOXINS; TIME FACTORS; TORTICOLLIS;

EID: 84939876587     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1253-8     Document Type: Article

References (8)

1. Dressler D (2004) Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov Disord Suppl 8:S92–S100
2. ®. Eur J Neurol 16(Suppl 2):2–5
3. Dressler D (2012) Five-year experience with incobotulinumtoxinA (Xeomin(®)): the first botulinum toxin drug free of complexing proteins. Eur J Neurol 19:385–389
4. Dressler D, Benecke R, Moore P, Dressler D, Naumann M (2003) Cervical and axial dystonia. In: Moore P, Naumann M (eds) Handbook of Botulinum Toxin Therapy, 2nd edn. Blackwell Science, Oxford, pp 158–194
5. Dressler D, Mander X, Fink K (2012) Meassuring the potency labelling of onabotulinumtoxinA (Botox®) and Xeomin® in an LD50 assay. J Neural Transm 119:13–15
6. Dressler D, Tacik P, Adib Saberi F (2014) Botulinum toxin therapy of cervical dystonia: comparing Botox® and Xeomin®. J Neural Transm 121:29–31
7. Probst TE, Heise H, Heise P, Benecke R, Dressler D (2002) Rare immunologic side effects of botulinum toxin therapy: brachial plexus neuropathy and dermatomyositis. Mov Disord 17(suppl 5):S49
8. Tsui JK, Calne DB (1988) Botulinum toxin in cervical dystonia. Adv Neurol 49:473–478